These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9263011)

  • 21. Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4+ T cells.
    Su SB; Gong W; Grimm M; Utsunomiya I; Sargeant R; Oppenheim JJ; Ming Wang J
    J Immunol; 1999 Jun; 162(12):7128-32. PubMed ID: 10358157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.
    Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL
    J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV glycoprotein gp120 inhibits TCR-CD3-mediated activation of fyn and lck.
    Morio T; Chatila T; Geha RS
    Int Immunol; 1997 Jan; 9(1):53-64. PubMed ID: 9043947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
    Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
    Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes.
    Babcock GJ; Mirzabekov T; Wojtowicz W; Sodroski J
    J Biol Chem; 2001 Oct; 276(42):38433-40. PubMed ID: 11489906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.
    Golding B; Inman J; Highet P; Blackburn R; Manischewitz J; Blyveis N; Angus RD; Golding H
    J Virol; 1995 Jun; 69(6):3299-307. PubMed ID: 7745677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of lymphocyte interaction with endothelium and homing by HIV-1 gp120.
    Bragardo M; Buonfiglio D; Feito MJ; Bonissoni S; Redoglia V; Rojo JM; Ballester S; Portoles P; Garbarino G; Malavasi F; Dianzani U
    J Immunol; 1997 Aug; 159(4):1619-27. PubMed ID: 9257821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.
    Bowman MR; MacFerrin KD; Schreiber SL; Burakoff SJ
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9052-6. PubMed ID: 1978941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120.
    Savarino A; Bensi T; Chiocchetti A; Bottarel F; Mesturini R; Ferrero E; Calosso L; Deaglio S; Ortolan E; Buttò S; Cafaro A; Katada T; Ensoli B; Malavasi F; Dianzani U
    FASEB J; 2003 Mar; 17(3):461-3. PubMed ID: 12551845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.
    Burkly L; Mulrey N; Blumenthal R; Dimitrov DS
    J Virol; 1995 Jul; 69(7):4267-73. PubMed ID: 7769687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.
    Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G
    J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
    Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
    Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4.
    Puigdomènech I; Massanella M; Izquierdo-Useros N; Ruiz-Hernandez R; Curriu M; Bofill M; Martinez-Picado J; Juan M; Clotet B; Blanco J
    Retrovirology; 2008 Mar; 5():32. PubMed ID: 18377648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
    Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
    J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.
    Nakamura GR; Byrn R; Wilkes DM; Fox JA; Hobbs MR; Hastings R; Wessling HC; Norcross MA; Fendly BM; Berman PW
    J Virol; 1993 Oct; 67(10):6179-91. PubMed ID: 7690420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
    Hivroz C; Mazerolles F; Soula M; Fagard R; Graton S; Meloche S; Sekaly RP; Fischer A
    Eur J Immunol; 1993 Mar; 23(3):600-7. PubMed ID: 7680610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule.
    Lamarre D; Capon DJ; Karp DR; Gregory T; Long EO; Sékaly RP
    EMBO J; 1989 Nov; 8(11):3271-7. PubMed ID: 2555159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multibranched peptide constructs derived from the V3 loop of envelope glycoprotein gp120 inhibit human immunodeficiency virus type 1 infection through interaction with CD4.
    Benjouad A; Chapuis F; Fenouillet E; Gluckman JC
    Virology; 1995 Jan; 206(1):457-64. PubMed ID: 7831801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.
    Masci AM; Galgani M; Cassano S; De Simone S; Gallo A; De Rosa V; Zappacosta S; Racioppi L
    J Leukoc Biol; 2003 Dec; 74(6):1117-24. PubMed ID: 12972513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.